Dr. Jeffrey N. Bryan, DVM, MS, PhD, DACVIM (Oncology) – University of Missouri
Dr. Noe Reyes, DVM – ELIAS Animal Health
Pilot Clinical Study to Evaluate the Combination of Gilvetmab and Adoptive Cell Therapy for Newly Diagnosed Metastatic Appendicular Osteosarcoma in Client-Owned Dogs.

Dr. Cheryl A. London, DVM PhD, ACVIM (O) – Tufts Cummings School of Veterinary Medicine
Pilot Study to Examine the Effects of Combined XPO1/PD1 Inhibition in Canine Cutaneous T Cell Lymphoma.

Dr. Kim A. Selting, CVM, MS, DACVIM (Oncology), DACVR (Radiation Oncology) – University of Illinois
Optimizing Hypofractionated Radiation to Maximally Harness the Immunogenic Potential of Anti-PD1 Canine Monoclonal Antibody for Oligometastatic Cancer.

Dr. David Vail, DVM, MS, DACVIM (Oncology) – University of Wisconsin
Radiotherapy/Immunocytokine-Induced In Situ Vaccination combined with Anti-PD1 in Dogs with Locally Advanced Melanoma.

Dr. David Vail, DVM, MS, DACVIM (Oncology) – University of Wisconsin
Translational Investigation of Low Dose Radiopharmaceutical Therapy in Combination with Immune Checkpoint Blockade and In Situ Vaccination in a Companion Canine Model.